We are back!


We are back!

After more than a year on the back-burner, CannabisIntel has re-engaged with an editor and will be publishing articles and news about the Australian and international medicinal cannabis industry.

The last year has seen a lot of changes in the industry here in Australia, from more players bringing products on the market and dropping prices to the TGA announcing their plans to add low-dose CBD to Schedule 3.

Watch this space to keep up with daily news and activity!

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Get all the latest content delivered straight to your inbox.”